P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

August 2011

Features

Clinical and Economic Impact of Early Versus Delayed 5-Alpha Reductase Inhibitor Therapy in Men Taking Alpha Blockers for Symptomatic Benign Prostatic Hyperplasia

Patients with prostatic enlargement who had taken an alpha blocker and were then given a 5-alpha reductase inhibitor earlier rather than later had a reduced risk of clinical progression, acute urinary retention, and prostate-related surgery, as well as lower medical costs.
Eric J. Kruep, PharmD, MS; Susan L. Hogue, PharmD, MPH; Michael T. Eaddy, PharmD, PhD; and Monica D. Chandra, MPP

Meeting Highlights

2011 American Society of Clinical Oncology

Therapies for melanoma; glioblastoma; non–small-cell lung cancer; gastrointestinal, prostate, and breast cancers; myelofibrosis; and markers for lymph-node mapping and antibody response
Walter Alexander

Book Review

An Overview of the Current Prescription Benefits Landscape

Pharmacy Benefits: Plan Design and Management by F. Randy Vogenberg, PhD, RPh

Reviewed by Joseph E. Biskupiak, PhD, MBA

Continuing Education Credit

Medication Management of Atrial Fibrillation

Emerging Therapies for Rhythm Control and Stroke Prevention

Non-drug strategies, new antiarrhythmic agents, and anticoagulants all help to reduce the risk of stroke and provide rhythm control. However, clinicians who prescribe these therapies must consider the patient’s other illnesses, manage drug interactions, minimize drug toxicity, adjust doses for renal impairment, and provide counseling on the risks of potential adverse effects.
Emily Knapp, PharmD, MBA; and Kristin Watson, PharmD, BCPS

Departments

Medication Errors

Keeping Patients Safe From Methadone Overdoses

Methadone must be administered with great caution.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Medullary thyroid cancer, restless legs syndrome, and preventing kidney transplant rejection
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Lurasidone HCl (Latuda), an Oral, Once-Daily Atypical Antipsychotic Agent for the Treatment of Patients with Schizophrenia

Lurasidone HCl (Latuda), an oral, atypical antipsychotic agent for schizophrenia
Martin P. Cruz, PharmD, CGP, BCPP